Cited by 295Carbohydrate Chemistry and SynthesisInfluenza Virus Research StudiesGlycosylation and Glycoproteins Research

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

Meindl, P., Bodo, G., Palese, P., Schulman, J., Tuppy, H.·1974·Virology

DOI 10.1016/0042-6822(74)90080-4

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0042-6822(74)90080-4

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids
Aminoff, D. (1961) · Biochemical Journal · doi:10.1042/bj0810384 · Cited by 1,898
Application of a Microtechnique to Viral Serological Investigations
Sever, J. L. (1962) · The Journal of Immunology · doi:10.4049/jimmunol.88.3.320 · Cited by 1,615
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein
Scheid, A., Caliguiri, L. A., Compans, R. W., & Choppin, P. W. (1972) · Virology · doi:10.1016/0042-6822(72)90418-7 · Cited by 325
Isolation and Purification of the Envelope Proteins of Newcastle Disease Virus
Scheid, A., & Choppin, P. W. (1973) · Journal of Virology · doi:10.1128/jvi.11.2.263-271.1973 · Cited by 293
Über 2-Desoxy-2.3-dehydro-sialinsäuren, II. Kompetitive Hemmung derVibrio-cholerae-Neuraminidase durch 2-Desoxy-2.3-dehyro-N-acyl-neuraminsäuren
Meindl, P., & Tuppy, H. (1969) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1969.350.2.1088 · Cited by 113
Self-citation
�ber 2-Deoxy-2,3-dehydro-sialins�uren, 1. Mitt.: Synthese und Eigenschaften von 2-Deoxy-2,3-dehydro-N-acylneuramins�uren und deren Methylestern
Meindl, P., & Tuppy, H. (1969) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/bf00903465 · Cited by 98
Self-citation
THE INHIBITION OF NEURAMINIDASE AND ANTIVIRAL ACTION
EDMOND, J. D., JOHNSTON, R. G., Kidd, D. A. A., Rylance, H. J., & Sommerville, R. G. (1966) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1966.tb01673.x · Cited by 62
Competitive inhibition of Vibrio cholerae neuraminic acids
Meindl, P. (1969) · Medical Entomology and Zoology · Cited by 61
Self-citation
Neuraminidase inhibition and viral chemotherapy
Haskell, T. H., Peterson, F. E., Watson, D., Plessas, N. R., & Culbertson, T. (1970) · Journal of Medicinal Chemistry · doi:10.1021/jm00298a027 · Cited by 51
Undisturbed release of influenza virus in the presence of univalent antineuraminidase antibodies
Becht, H., Hämmerling, U., & ROTT, R. (1971) · Virology · doi:10.1016/0042-6822(71)90035-3 · Cited by 51

Show all 17 references

Research works printed but not linked: 1

Kilborune, 1967, Antigenic hybrids of influenza viruses and their implications, Vol. 5, 87

Sorted by citations

Biological roles of glycans
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“The elegant structure-based design of a modified version of the previously known sialidase inhibitor Neu5Ac2en (791) gave rise to the potent and specific inhibitor zanamivir (Relenza) (792, 793), and later to the structurally related agent oseltamivir (Tamiflu) (794, 795).”
Background
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity
Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., Tai, C. Y., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963036t · Cited by 1,100
Neuraminidase Inhibitors for Influenza
Moscona, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050740 · Cited by 1,103
Chemistry, Metabolism, and Biological Functions of Sialic Acids
Schauer, R. (1982) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(08)60109-2 · Cited by 1,013
Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin
Rogers, G. N., & Paulson, J. C. (1983) · Virology · doi:10.1016/0042-6822(83)90150-2 · Cited by 943
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Russell, R. J. M., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., Blackburn, G. M., Hay, A. J., Gamblin, S. J., & Skehel, J. J. (2006) · Nature · doi:10.1038/nature05114 · Cited by 822
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 788
Self-citation
Glycosidase inhibitors: update and perspectives on practical use
Asano, N. (2003) · Glycobiology · doi:10.1093/glycob/cwg090 · Cited by 717
Parainfluenza Viruses
Henrickson, K. J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.242-264.2003 · Cited by 497
Drug resistance in influenza A virus: the epidemiology and management
Hussain, M., Galvin, H. D., Haw, T. Y., Nutsford, A. N., & Husain, M. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s105473 · Cited by 451
The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor
Varghese, J. N., McKimm‐Breschkin, J. L., Caldwell, J. B., Kortt, A. A., & Colman, P. M. (1992) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340140302 · Cited by 402
BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design
Babu, Y. S., Chand, P., Bantia, S., Kotian, P. L., Dehghani, A., El-Kattan, Y. A., Lin, T., Hutchison, T. L., Elliott, A. J., Parker, C. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002679 · Cited by 385
Adult and embryonic mouse neural cell adhesion molecules have different binding properties
Sadoul, R., Hirn, M. H., Bazin, H., Rougon, G. N., & Goridis, C. (1983) · Nature · doi:10.1038/304347a0 · Cited by 351
Influenza virus neuraminidase: Structure, antibodies, and inhibitors
Colman, P. M. (1994) · Protein Science · doi:10.1002/pro.5560031007 · Cited by 334
Exploration of the Sialic Acid World
Schauer, R., & Kamerling, J. P. (2018) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/bs.accb.2018.09.001 · Cited by 328
4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
Woods, J. M., Bethell, R. C., Coates, J. A., Healy, N., Hiscox, S. A., Pearson, B. A., Ryan, D., Ticehurst, J. R., Tilling, J., & Walcott, S. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1473 · Cited by 312
Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza
Hayden, F. G. (1996) · JAMA · doi:10.1001/jama.1996.03530280047035 · Cited by 291
Carbohydrate-based drugs launched during 2000−2021
Cao, X., Du, X., Jiao, H., An, Q., Chen, R., Fang, P., Wang, J., & Yu, B. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.020 · Cited by 285
Chemistry, biochemistry and biology of sialic acids
Schauer, R., & Kamerling, J. P. (1997) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60624-9 · Cited by 223
Synthetic Approaches to the Neuraminidase Inhibitors Zanamivir (Relenza) and Oseltamivir Phosphate (Tamiflu) for the Treatment of Influenza
Magano, J. (2009) · Chemical Reviews · doi:10.1021/cr800449m · Cited by 218
Gangliosides
Wiegandt, H. (1985) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60022-8 · Cited by 217
Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase
Varghese, J. N., Smith, P. W., Sollis, S. L., Blick, T., Sahasrabudhe, A., McKimm‐Breschkin, J. L., & Colman, P. M. (1998) · Structure · doi:10.1016/s0969-2126(98)00075-6 · Cited by 202
Molecular forms of N-CAM and its RNA in developing and denervated skeletal muscle.
Covault, J., Merlie, J. P., Goridis, C., & Sanes, J. R. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.102.3.731 · Cited by 189
Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity
Chand, P., Kotian, P. L., Dehghani, A., El-Kattan, Y. A., Lin, T., Hutchison, T. L., Babu, Y. S., Bantia, S., Elliott, A. J., & Montgomery, J. A. J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010277p · Cited by 175
Antiviral Approaches against Influenza Virus
Kumari, R., Sharma, S. D., Kumar, A., Ende, Z. S., Mishina, M., Wang, Y., Falls, Z., Samudrala, R., Pohl, J., Knight, P. R., et al. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-22 · Cited by 176
Enzymatic Two‐Step Synthesis of N‐Acetyl‐neuraminic Acid in the Enzyme Membrane Reactor
Kragl, U., Gygax, D., Ghisalba, O., & Wandrey, C. (1991) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199108271 · Cited by 169
Old tricks, new dogs: organocatalytic dienamine activation of α,β-unsaturated aldehydes
Marcos, V., & Alemán, J. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00438e · Cited by 166
Influenza neuraminidase: A druggable target for natural products
Grienke, U., Schmidtke, M., von Grafenstein, S., Kirchmair, J., Liedl, K. R., & Rollinger, J. M. (2011) · Natural Product Reports · doi:10.1039/c1np00053e · Cited by 158
Lectin receptors as markers for Trypanosoma cruzi. Developmental stages and a study of the interaction of wheat germ agglutinin with sialic acid residues on epimastigote cells.
Pereira, M., Loures, M. A. L., Villalta, F., & Andrade, A. F. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.5.1375 · Cited by 158
An enzymatic assay reveals that proteins destined for the apical or basolateral domains of an epithelial cell line share the same late Golgi compartments.
Fuller, S. D., Bravo, R., & Simons, K. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03629.x · Cited by 157
Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position
Holzer, C. T., von Itzstein, M., Jin, B., Pegg, M. S., Stewart, W. P., & Wu, W.-Y. (1993) · Glycoconjugate Journal · doi:10.1007/bf00731185 · Cited by 155
Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells
Schulman, J. L., & Palese, P. (1977) · Journal of Virology · doi:10.1128/jvi.24.1.170-176.1977 · Cited by 140
Self-citation
Gangliosides as influenza virus receptors. Variation of influenza viruses and their recognition of the receptor sialo-sugar chains
Suzuki, Y. (1994) · Progress in Lipid Research · doi:10.1016/0163-7827(94)90026-4 · Cited by 139
Studies on cell adhesion and recognition. I. Extent and specificity of cell adhesion triggered by carbohydrate-reactive proteins (glycosidases and lectins) and by fibronectin.
Rauvala, H., Carter, W. G., & Hakomori, S. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.88.1.127 · Cited by 138
Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview
Villar, E., & Muñoz‐Barroso, I. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-5433-0 · Cited by 130
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus
Tumpey, T. M., García‐Sastre, A., Mikulasova, A., Taubenberger, J. K., Swayne, D. E., Palese, P., & Basler, C. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519699 · Cited by 127
Self-citation
An efficient process for production of n-acetylneuraminic acid using n-acetylneuraminic acid aldolase
Mahmoudian, M., NOBLE, D., Drake, C. S., Middleton, R. F., Montgomery, D. S., Piercey, J. E., Ramlakhan, D., Todd, M., & Dawson, M. J. (1997) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(96)00180-9 · Cited by 127
Anti-influenza agents from Traditional Chinese Medicine
Hu, G., Wang, Y., Xu, J., Gu, Q., Liu, H.-B., Xiao, P., Zhou, J., Liu, Y., Yang, Z., & Su, H. (2010) · Natural Product Reports · doi:10.1039/c0np00005a · Cited by 123
New Approaches to Influenza Chemotherapy
Calfee, D. P., & Hayden, F. G. (1998) · Drugs · doi:10.2165/00003495-199856040-00003 · Cited by 120
Reconstitution of an endocytic fusion event in a cell-free system
Davey, J. F., Hurtley, S. M., & Warren, G. (1985) · Cell · doi:10.1016/0092-8674(85)90236-3 · Cited by 118
Metabolism of Sialic Acids
Corfield, A. P., & Schauer, R. (1982) · Cell biology monographs · doi:10.1007/978-3-7091-8680-0_9 · Cited by 117
Molecular heterogeneity and structural evolution during cerebellar ontogeny detected by monoclonal antibody of the mouse cell surface antigen BSP-2
Hirn, M. H., Ghandour, M. S., Bazin, H., & Goridis, C. (1983) · Brain Research · doi:10.1016/0006-8993(83)91337-9 · Cited by 115
Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA)
Palese, P., Schulman, J. L., Bodo, G., & Meindl, P. (1974) · Virology · doi:10.1016/0042-6822(74)90458-9 · Cited by 113
Self-citation
Ligand recognition by influenza virus. The binding of bivalent sialosides.
Glick, G. D., Toogood, P. L., Wiley, D. C., Skehel, J. J., & Knowles, J. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54335-0 · Cited by 113
Antivirals Targeting Influenza A Virus
Das, K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300455c · Cited by 112
Multiple oligosaccharide chains in the voltage-sensitive Na channel from Electrophorus electricus: Evidence for α-2,8-linked polysialic acid
James, W. M., & Agnew, W. S. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90949-1 · Cited by 110
Molecular aspects of immunoglobulin A1 degradation by oral streptococci
Reinholdt, J., Tomana, M., Mortensen, S. B., & Kilian, M. (1990) · Infection and Immunity · doi:10.1128/iai.58.5.1186-1194.1990 · Cited by 107
Thyroglobulin interactions with thyroid plasma membranes. the existence of specific receptors and their potential role
Consiglio, E., Salvatore, G., Rall, J. E., & Kohn, L. D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50561-5 · Cited by 98
Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza
Smee, D. F., & Sidwell, R. W. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.6.859 · Cited by 94
In vivo anti-influenza virus activity of plant flavonoids possessing inhibitory activity for influenza virus sialidase
Nagai, T., Miyaichi, Y., Tomimori, T., Suzuki, Y., & Yamada, H. (1992) · Antiviral Research · doi:10.1016/0166-3542(92)90080-o · Cited by 92
Comparative Binding Energy (COMBINE) Analysis of Influenza Neuraminidase−Inhibitor Complexes
Wang, T., & Wade, R. C. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001070j · Cited by 90
Synthesis of the potent influenza neuraminidase inhibitor 4-guanidino Neu5Ac2en. X-Ray molecular structure of 5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-D-erythro-L-gluco-nononic acid
Chandler, M., Bamford, M. J., Conroy, R., Lamont, B., Patel, B., Patel, V. K., Steeples, I. P., Storer, R., Weir, N. G., Wright, M., et al. (1995) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19950001173 · Cited by 89
The HN glycoprotein of sendai virus: Analysis of site(s) involved in hemagglutinating and neuraminidase activities
Portner, A. (1981) · Virology · doi:10.1016/0042-6822(81)90118-5 · Cited by 87
The hemagglutinating and neuraminidase protein of a paramyxovirus: Interaction with neuraminic acid in affinity chromatography
Scheid, A., & Choppin, P. W. (1974) · Virology · doi:10.1016/0042-6822(74)90308-0 · Cited by 86
Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis
Nagai, T., Moriguchi, R., Suzuki, Y., Tomimori, T., & Yamada, H. (1995) · Antiviral Research · doi:10.1016/0166-3542(94)00062-d · Cited by 85
The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA
Greengard, O., Poltoratskaia, N., Leikina, E., Zimmerberg, J. J., & Moscona, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11108-11114.2000 · Cited by 84
Influenza Virus Resistance to Antiviral Therapy
van der Vries, E., Schutten, M., Fraaij, P. L. A., Boucher, C. A., & Osterhaus, A. D. M. E. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-405880-4.00006-8 · Cited by 84
Low-density lipoprotein modification occurring in human plasma
Tertov, V. V., Kaplun, V. V., Sobenin, I. A., & Orekhov, A. N. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00023-9 · Cited by 84
Total Synthesis of A-315675: A Potent Inhibitor of Influenza Neuraminidase
Hanessian, S., Bayrakdarian, M., & Luo, X. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0126226 · Cited by 83
Studies on cell adhesion and recognition. II. The kinetics of cell adhesion and cell spreading on surfaces coated with carbohydrate-reactive proteins (glycosidases and lectins) and fibronectin.
Carter, W. G., Rauvala, H., & Hakomori, S. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.88.1.138 · Cited by 82
Progress of small molecular inhibitors in the development of anti-influenza virus agents
Wu, X., Wu, X., Sun, Q., Zhang, C., Yang, S., Li, L., & Jia, Z. (2017) · Theranostics · doi:10.7150/thno.17071 · Cited by 79
The Biological Role of Sialic Acid at the Surface of the Cell
Jeanloz, R. W., & Codington, J. F. (1976) · Springer eBooks · doi:10.1007/978-1-4684-2226-9_7 · Cited by 80
Neuraminidase Inhibitors as Anti-Influenza Virus Agents
Kim, C. U., Chen, X., & Mendel, D. B. (1999) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029901000401 · Cited by 76
Conotoxins and their potential pharmaceutical applications
Adams, D. J., Alewood, P. F., Craik, D. J., Drinkwater, R. D., & Lewis, R. J. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199903/04)46:3/4 · Cited by 104
NMR Spectroscopy of Sialic Acids
Vliegenthart, J. F. G., DORLAND, L., van HALBEEK, H., & Haverkamp, J. (1982) · Cell biology monographs · doi:10.1007/978-3-7091-8680-0_7 · Cited by 74
‘Flu’ and structure-based drug design
Wade, R. C. (1997) · Structure · doi:10.1016/s0969-2126(97)00265-7 · Cited by 72
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis
Muthuri, S. G., Venkatesan, S., Myles, P. R., Leonardi‐Bee, J., Lim, W. S., Mamun, A. A., Anovadiya, A., de Araújo, W. N., Azziz‐Baumgartner, E., Báez, C., et al. (2015) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12363 · Cited by 67
Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo
Chand, P., Bantia, S., Kotian, P. L., El-Kattan, Y. A., Lin, T., & Babu, Y. S. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.03.048 · Cited by 66
Sialidase Inhibitors with Different Mechanisms
Keil, J. M., Rafn, G. R., Turan, I. M., Aljohani, M. A., Sahebjam-Atabaki, R., & Sun, X. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01258 · Cited by 69
Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice
White, E. J., Gyulay, G., Lhoták, Š., Szewczyk, M. M., Chong, T. M., Fuller, M. T., Dadoo, O., Fox‐Robichaud, A., Austin, R. C., Trigatti, B. L., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004589 · Cited by 64
Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart
Fryer, A. D., El‐Fakahany, E. E., & Jacoby, D. B. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90244-z · Cited by 64
Current and novel antiviral strategies for influenza infection
Yen, H. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.05.004 · Cited by 63
Sendai virus-erythrocyte membrane interaction: quantitative and kinetic analysis of viral binding, dissociation, and fusion
Hoekstra, D., & Klappe, K. (1986) · Journal of Virology · doi:10.1128/jvi.58.1.87-95.1986 · Cited by 62
MANAGING INFLUENZA: AMANTADINE, RIMANTADINE AND BEYOND
Fleming, D. (2001) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2001.tb11012.x · Cited by 60
Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase
Birch, L. M., Murray, C. W., Hartshorn, M. J., Tickle, I. J., & Verdonk, M. L. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1023844626572 · Cited by 60
2,3-dehydro-4-epi-N-acetylneuraminic acid; a neuraminidase inhibitor
Kumar, V., Kessler, J., Scott, M. E., PATWARDHAN, B. H., Tanenbaum, S. W., & Flashner, M. (1981) · Carbohydrate Research · doi:10.1016/s0008-6215(00)80711-9 · Cited by 60
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses
Wen, W., Wang, S., Tsai, K., Cheng, Y. E., Yang, A., Fang, J., & Wong, C. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.010 · Cited by 59
New ganglioside analogs that inhibit influenze virus sialidase
Suzuki, Y., Sato, K., Kiso, M., & Hasegawa, A. (1990) · Glycoconjugate Journal · doi:10.1007/bf01073378 · Cited by 58
Inhibition of Parainfluenza Virus Type 3 and Newcastle Disease Virus Hemagglutinin-Neuraminidase Receptor Binding: Effect of Receptor Avidity and Steric Hindrance at the Inhibitor Binding Sites
Porotto, M., Murrell, M. T., Greengard, O., Lawrence, M. C., McKimm‐Breschkin, J. L., & Moscona, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13911-13919.2004 · Cited by 57
Antivirals against animal viruses
Villa, T. G., Feijoo-Siota, L., Rama, J. L. R., & Ageitos, J. M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.029 · Cited by 54
Anti-Influenza Drugs: The Development of Sialidase Inhibitors
von Itzstein, M., & Thomson, R. J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-79086-0_5 · Cited by 53
Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guanidino-Neu5Ac2en (GG167) with modified 5-substituents
Smith, P., Starkey, I. D., HOWES, P. D., Sollis, S. L., Keeling, S. P., Cherry, P., von Itzstein, M., Wu, W., & Jin, B. (1996) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(96)80447-8 · Cited by 50
Oseltamivir-resistant influenza?
Moscona, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16947-x · Cited by 50
On the side-chain conformation of N-acetylneuraminic acid and its epimers at C-7, C-8, and C-7,8
Christian, R., Schulz, G., Brandstetter, H. H., & Zbiral, E. (1987) · Carbohydrate Research · doi:10.1016/0008-6215(87)80195-7 · Cited by 49
An efficient method for introducing defined lipids into the plasma membrane of mammalian cells.
Gerrit van, M. E. E. R., & Simons, K. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.97.5.1365 · Cited by 47
Neuraminidase Inhibitors and their Role in Avian and Pandemic Influenza
Crusat, M., & de Jong, M. D. (2007) · Antiviral Therapy · doi:10.1177/135965350701200s07.1 · Cited by 45
Synthesis of a Phosphonic Acid Analogue of N‐Acetyl‐2,3‐didehydro‐2‐deoxyneuraminic Acid, an Inhibitor of Vibrio cholerae Sialidase
Vasella, A. T., & Wyler, R. (1991) · Helvetica Chimica Acta · doi:10.1002/hlca.19910740223 · Cited by 46
Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease
Bowles, W., & Gloster, T. M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.705133 · Cited by 45
Recent Advances in Computer-Aided Drug Design as Applied to Anti-Influenza Drug Discovery
Mallipeddi, P. L., Kumar, G., White, S. W., & Webb, T. R. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140929153812 · Cited by 44
2,3-Didehydro-2-deoxysialic acids structurally varied at C-5 and their behaviour towards the sialidase from Vibrio cholerae
Schreiner, E. P., Zbiral, E., Kleineidam, R. G., & Schauer, R. (1992) · Carbohydrate Research · doi:10.1016/0008-6215(92)84150-q · Cited by 43
Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase
Chand, P., Kotian, P. L., Morris, P. E., Bantia, S., Walsh, D. A., & Babu, Y. S. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.01.042 · Cited by 43
A rapid and sensitive assay for neuraminidase using peanut lectin hemagglutination: Application to Vibrio cholera and Trypanosoma cruzi
Pereira, M. E. A. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90206-5 · Cited by 43
Synaptosomal Sialyltransferase Glycosylates Surface Proteins that Are Inaccessible to the Action of Membrane‐Bound Sialidase
Breen, K. C., & Regan, C. M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00737.x · Cited by 43
Novel α- and β-Amino Acid Inhibitors of Influenza Virus Neuraminidase
Kati, W. M., Montgomery, D., Maring, C. J., Stoll, V. S., Giranda, V. L., Chen, X., Laver, W. G., Kohlbrenner, W. E., & Norbeck, D. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2563-2570.2001 · Cited by 42
Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface
Hu, H., Shioda, T., Moriya, C., Xin, X., Hasan, M. K., Miyake, K., Shimada, T., & Nagai, Y. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7462-7470.1996 · Cited by 42
Strategies for Antiviral Drug Discovery
Jones, P. (1998) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029800900401 · Cited by 41
Oseltamivir Analogues Bearing N-Substituted Guanidines as Potent Neuraminidase Inhibitors
Mooney, C. A., Johnson, S. A., Hart, P. ‘., van Ufford, L. Q., de Haan, C. A. M., Moret, E. E., & Martin, N. I. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401977j · Cited by 40
A fusing mumps virus variant selected from a nonfusing parent with the neuraminidase inhibitor 2-Deoxy-2,3-dehydro-N-acetylneuraminic acid
Waxham, M. N., & S.Wolinsky, J. (1986) · Virology · doi:10.1016/0042-6822(86)90050-4 · Cited by 40
Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design
Mtambo, S. E., Amoako, D. G., Somboro, A. M., Agoni, C., Lawal, M. M., Gumede, N. S., Khan, R. B., & Kumalo, H. M. (2021) · Molecules · doi:10.3390/molecules26040880 · Cited by 45

Authors: Meindl, P., Bodo, G., Palese, P., Schulman, J., & Tuppy, H.
Affiliations: Icahn School of Medicine at Mount Sinai (US)
University of Vienna (AT)
ORCID: Palese, P.
Venue: Virology
Publisher: Elsevier BV
Published: 1974-04
Volume: 58
Issue: 2
Pages: 457-463
ISSN: 0042-6822 (ISSN-L)
DOI: 10.1016/0042-6822(74)90080-4
OpenAlex: W2088195624
Cited by: 287
References: 17
Citations by year: 2026: 2 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 8 · 2016: 15 · 2015: 4 · 2014: 8 · 2013: 6 · 2012: 9
FWCI: 7.12
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Virology (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords: neuraminidase inhibitors, Vibrio cholerae neuraminidase, competitive inhibition, enzyme inhibition constants, hemagglutination inhibition, Sendai virus, sialic acid analogues
MeSH terms: Hemagglutination Inhibition Tests, Hemagglutination, Viral, Humans, Neuraminic Acids, Neuraminidase, Newcastle disease virus, Orthomyxoviridae, Parainfluenza Virus 1, Human, Vibrio cholerae, Respirovirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks